Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo.
Rudicell, R.S., Kwon, Y.D., Ko, S.Y., Pegu, A., Louder, M.K., Georgiev, I.S., Wu, X., Zhu, J., Boyington, J.C., Chen, X., Shi, W., Yang, Z.Y., Doria-Rose, N.A., McKee, K., O'Dell, S., Schmidt, S.D., Chuang, G.Y., Druz, A., Soto, C., Yang, Y., Zhang, B., Zhou, T., Todd, J.P., Lloyd, K.E., Eudailey, J., Roberts, K.E., Donald, B.R., Bailer, R.T., Ledgerwood, J., Mullikin, J.C., Shapiro, L., Koup, R.A., Graham, B.S., Nason, M.C., Connors, M., Haynes, B.F., Rao, S.S., Roederer, M., Kwong, P.D., Mascola, J.R., Nabel, G.J.
J.Virol.
